Novel Anti-acne Therapeutics (with Curl Bio)
Acne
Pre-clinicalActive
Key Facts
About ZenBio
ZenBio is a long-established provider of critical biological research tools and contract services, with a core focus on human adipocytes and stem cells for regenerative medicine and cosmetics applications. The company has built a reputation for high-quality, consistent cell-based products and has recently expanded its capabilities into exosome and extracellular vesicle therapeutics, as evidenced by multiple awarded SBIR grants. In August 2024, ZenBio was acquired by BioIVT, a strategic move that integrates it into a larger global research model provider, enhancing its distribution and service reach while continuing its independent research programs.
View full company profileTherapeutic Areas
Other Acne Drugs
| Drug | Company | Phase |
|---|---|---|
| B244 | AOBiome | Phase 2 |
| ADA-308 | Aranda Pharma | Pre-clinical |
| Living Skin Probiotic Program | S-biomedic | Pre-clinical/Clinical |
| Vincobiosis® Acneic | Laboratorio Reig Jofre | Launched |
| BTX 1503 | Botanix Pharmaceuticals | Phase 2 |
| Pyrilutamide | Kintor Pharma | Phase 2 |